Registered entities
Sorrento Therapeutics, Inc
Reg. No. 33-0344842United States
Sorrento Therapeutics, Inc.
Reg. No. 850261United States
Innovation
169 patent families (75 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 12,878 times.
| Year | Filings |
|---|---|
| 2015 | 28 |
| 2016 | 33 |
| 2017 | 40 |
| 2018 | 55 |
| 2019 | 61 |
| 2020 | 52 |
| 2021 | 67 |
| 2022 | 77 |
| 2023 | 65 |
| 2024 | 44 |
| 2025 | 8 |
| 2026 | 3 |
Investor mix
11 investors on record; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 27% |
| Private equity | 3 | 27% |
| Bank & private debt | 1 | 9% |
| Other / undisclosed | 4 | 36% |